Our Regenerative Medicine Technologies

Renovos is backed by decades of academic research and deep understanding of stem cells, tissue engineering, biomaterials and the clinical orthobiologic fields.

The core focus of Renovos is addressing the unmet clinical needs within regenerative medicine by developing a proprietary platform technology based on synthetic nanoclay gels, RENOVITE^®.  RENOVITE^® acts as injectable scaffold which attracts regenerative cells and localises and retains delivered biologics at ultra-low effective doses for safer and more efficient applications in tissue regeneration.

Our commercial proposition includes research-grade primary mesenchymal stem cells for research, sourced from elderly and orthopaedic patient cohorts.